[The delta sleep-inducing peptide, its analogs and the serotoninergic system in the development of anticonvulsant action].
Shandra. A A AA; Godlevskiĭ. L S LS; Brusentsov. A I AI; Petrashevich. V P VP; Vast'ianov. R S RS; Nickel. B B; Mikhaleva. I I II
Key Findings
- DSIP and its analogues showed seizure‑protecting effects.
- DSIP increased the uptake (sorption) of radioactive tryptophan in the brain.
- The serotonin system does not appear to be essential for DSIP’s anticonvulsant action.
Practical Outcomes
- For most biohackers, this research offers limited immediate use. It suggests DSIP might have potential as an anti‑seizure agent, but no dosing guidelines or clear benefits for longevity, metabolism, or performance are provided. Until more human data emerge, it’s not a practical supplement for everyday protocols.
Summary
The study found that the peptide delta‑sleep‑inducing peptide (DSIP) and similar compounds can help protect against seizures in animal tests. They also cause the brain to take up more tryptophan, but this effect doesn’t seem to rely on the serotonin system.
Abstract
A seizure-protecting effect of the delta-sleep-inducing peptide (DSIP) and its analogues was revealed. An intensive sorption of H3 tryptophan occurred under the effect of the DSIP and its analogues. The data obtained suggests that the serotoninergic system plays no important part in the seizure-protecting effect.
Study Information
pubmed
1997